Correlation Between Biocardia and AIM ImmunoTech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Biocardia and AIM ImmunoTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biocardia and AIM ImmunoTech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biocardia and AIM ImmunoTech, you can compare the effects of market volatilities on Biocardia and AIM ImmunoTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biocardia with a short position of AIM ImmunoTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biocardia and AIM ImmunoTech.

Diversification Opportunities for Biocardia and AIM ImmunoTech

0.57
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Biocardia and AIM is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Biocardia and AIM ImmunoTech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AIM ImmunoTech and Biocardia is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biocardia are associated (or correlated) with AIM ImmunoTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AIM ImmunoTech has no effect on the direction of Biocardia i.e., Biocardia and AIM ImmunoTech go up and down completely randomly.

Pair Corralation between Biocardia and AIM ImmunoTech

Given the investment horizon of 90 days Biocardia is expected to under-perform the AIM ImmunoTech. In addition to that, Biocardia is 2.18 times more volatile than AIM ImmunoTech. It trades about -0.02 of its total potential returns per unit of risk. AIM ImmunoTech is currently generating about -0.01 per unit of volatility. If you would invest  49.00  in AIM ImmunoTech on September 2, 2024 and sell it today you would lose (26.00) from holding AIM ImmunoTech or give up 53.06% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Biocardia  vs.  AIM ImmunoTech

 Performance 
       Timeline  
Biocardia 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biocardia has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
AIM ImmunoTech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AIM ImmunoTech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Biocardia and AIM ImmunoTech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Biocardia and AIM ImmunoTech

The main advantage of trading using opposite Biocardia and AIM ImmunoTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biocardia position performs unexpectedly, AIM ImmunoTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AIM ImmunoTech will offset losses from the drop in AIM ImmunoTech's long position.
The idea behind Biocardia and AIM ImmunoTech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios